14 November 2020 - Late treatment study
Utility of Ivermectin and Doxycycline combination for the treatment of SARSCoV-2
et al., IAIM, 2020, 7:10, 177-182 (Peer Reviewed)
100 patient prospective trial of ivermectin + doxycycline showing reduced time to symptom resolution and shorter hospital stay with treatment.
|
recovery time, 21.1% lower, relative time 0.79, p = 0.03, treatment 50, control 50.
|
|
hospitalization time, 15.5% lower, relative time 0.84, p = 0.01, treatment 50, control 50.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
Spoorthi et al., 11/14/2020, prospective, India, South Asia, peer-reviewed, 2 authors, dosage not specified, this trial uses multiple treatments in the treatment arm (combined with doxycycline) - results of individual treatments may vary.
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All
practical, effective, and safe means should be used. Elimination of COVID-19
is a race against viral evolution. No treatment, vaccine, or intervention is
100% available and effective for all current and future variants. Denying the
efficacy of any method increases the risk of COVID-19 becoming endemic; and
increases mortality, morbidity, and collateral damage. We do not provide
medical advice. Before taking any medication, consult a qualified physician
who can provide personalized advice and details of risks and benefits based
on your medical history and situation. Treatment protocols for physicians are
available from the FLCCC.